Policy / Pricing EU invests 30m to fight antimicrobial resistance PharmaphorumThe EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.Policy / PricingInfectious DiseaseRead full story pharminent April 8, 2026 (Last updated: April 8, 2026) Pharmaphorum The EU has pledged 30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials. Policy / PricingInfectious DiseaseRead full story Post navigation Previous: RoosterBio and MineBio team up to expand MSC solutions access in ChinaNext: List Price Reductions Will Deflate the Gross-to-Net Bubble-and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun) Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
